" /> B Acute Lymphoblastic Leukemia, BCR-ABL1-Like - CISMeF





Preferred Label : B Acute Lymphoblastic Leukemia, BCR-ABL1-Like;

NCIt synonyms : Ph-Like ALL; B Acute Lymphoblastic Leukemia with BCR-ABL1-Like Features; B Lymphoblastic Leukemia, Philadelphia-like; B-Acute Lymphoblastic Leukemia with BCR-ABL1-Like Features; B Acute Lymphoblastic Leukemia with BCR::ABL1-Like Features; B-Acute Lymphoblastic Leukemia with BCR::ABL1-Like Features; B-Lymphoblastic Leukemia, Philadelphia-like; Ph-Like Acute Lymphoblastic Leukemia; B-Acute Lymphoblastic Leukemia, BCR-ABL1-Like; B-Acute Lymphoblastic Leukemia, BCR::ABL1-Like; B Acute Lymphoblastic Leukemia, BCR::ABL1-Like;

NCIt related terms : Ph-Like; BCR-ABL1-like Acute Lymphoblastic Leukemia; BCR-ABL1-like ALL; Philadelphia-Like Acute Lymphoblastic Leukemia; Philadelphia-like ALL; BCR::ABL1-like features;

NCIt definition : B acute lymphoblastic leukemia characterized by a gene-expression profile similar to that of BCR-ABL1-positive B acute lymphoblastic leukemia, absence of the pathognomonic BCR-ABL1 rearrangement, alterations of lymphoid transcription factor genes, and a poor outcome.;

Alternative definition : NICHD: A subtype of high risk B cell acute lymphoblastic leukemia (ALL) in which patients have a gene-expression profile similar to that of BCR-ABL1 positive ALL, but who all lack the BCR-ABL1 fusion gene. Similar to patients with BCR-ABL1 positive ALL, patients with Ph-like ALL frequently harbor alterations in lymphoid transcription factors. This is clinically important because of the presence of kinase-activating alterations that are amenable to treatment with currently available tyrosine kinase inhibitors. This subtype occurs in 10-15% of pediatric ALL patients and increases in frequency with age.;

Neoplastic status : Malignant;

Details


You can consult :


Nous contacter.
12/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.